Silver Oak Securities »

SAB Biotherapeutics shares owned by Silver Oak Securities

Quarter-by-quarter ownership of SAB Biotherapeutics shares owned by Silver Oak Securities from 13F filings

Historical chart of Silver Oak Securities investment in SAB Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including SAB Biotherapeutics held by Silver Oak Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in SAB Biotherapeutics by Silver Oak Securities

Quarter filed Position value Share count Share price at filing
2023-12-31 $36k 52k 0.69
2023-09-30 $43k 52k 0.83
2023-06-30 $43k 52k 0.83
2023-03-31 $23k 52k 0.44
2022-12-31 $31k 52k 0.60
2022-06-30 $64k 52k 1.23

More positions owned by Silver Oak Securities

First Tr Exchange-traded Cap Strength Etf (FTCS)
Victory Portfolios Ii Vcshs Us Eq Incm (CDC)
First Tr Lrge Cp Core Alpha Com Shs (FEX)
Ishares Tr 0-5 Yr Tips Etf (STIP)
First Tr Value Line Divid In SHS (FVD)
Apple (AAPL)
First Tr Exchange-traded Risng Divd Achiv (RDVY)
Wisdomtree Tr Floatng Rat Trea (USFR)
Victory Portfolios Ii Vcshs Us 500 Vol (CFA)
Capital Group Dividend Value Shs Creation Uni (CGDV)
Ishares Tr TRS FLT RT BD (TFLO)
Spdr Ser Tr Prtflo S&p500 Gw (SPYG)
Ishares Tr Global 100 Etf (IOO)
Invesco Exch Trd Slf Idx Rusl 1000 Dynm (OMFL)
Schwab Strategic Tr Us Dividend Eq (SCHD)

View all positions for Silver Oak Securities

Top funds holding SAB Biotherapeutics

BVF
Sessa Capital IM
Pathstone Holdings
Kestra Advisory Services
Mariner Wealth Advisors
Creative Planning
Citadel Advisors
Baird Financial
LM Advisors
UBS Group
Royal Bank of Canada
Bank of America Corporation

View all funds holding SAB Biotherapeutics